Corinne grew up in Newton Center, Massachusetts and Lake Forest, Illinois before heading across the country to attend Stanford. After graduating as an industrial engineering major and then earning her MBA at HBS, Corinne worked as an investment banker specializing in healthcare at firms such as Kidder Peabody, Dillon Read and UBS.
Catching the itch to join an operating company, Corinne became CFO of Tularik, a biotech company, and led the company’s IPO. From there, she joined Edwards Lifesciences as CFO and subsequently assumed the role of President of Global Operations and GM of the CardioVascular Division.
Corinne now serves on six public boards, including the US Olympic and Paralympic Foundation and three publicly traded therapeutics companies: Onyx Pharmaceuticals (sold to Amgen), Avanir (sold to Otsuka), and Neurocrine Biosciences.
Of her many achievements, Corinne’s proudest accomplishment has been raising her two sons, William and Konrad.